Doctor profile · Federal record
Dr. Hownaz Binavi, NP
Nurse Practitioner · San Diego, CA
- NPI 1083276273
- Accepts Medicare
- 8 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
6280 Jackson Dr Ste 8
San Diego, CA 921193436
(619) 464-1608 - Mailing address
-
2285 Corporate Cir, Ste 200
Henderson, NV 890747759
Credentials & registration
- NPI registered
- July 2019 — 7 yrs on file
- Profile last updated
- February 11, 2020
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- California #95010956
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1083276273. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
686
Distinct HCPCS
10
Medicare allowed
$42,264
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 255 | 38 | $7 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 95 | 69 | $117 | |
11102 |
Biopsy of related skin growth, first growth | 67 | 63 | $91 | |
17000 |
Destruction of precancer skin growth, 1 growth | 59 | 55 | $53 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 54 | 54 | $151 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 43 | 39 | $83 | |
17110 |
Destruction of skin growth, 1-14 growths | 32 | 31 | $110 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 26 | 23 | $52 | |
11103 |
Biopsy of related skin growth, each additional growth | 25 | 18 | $48 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 15 | 15 | $67 |
In context: peer comparison
Among 53 peers in San Diego Nurse Practitioner, average services per provider: 106. This provider delivers 6.5× the peer median.Open Payments
Industry payments received
All-time total
$2,667
Transactions
136
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Incyte Corporation | 20 | $460.00 | |
| Abbvie INC. | 18 | $379.86 | |
| Janssen Biotech, INC. | 16 | $327.13 | |
| Pfizer INC. | 13 | $222.55 | |
| Sun Pharmaceutical Industries INC. | 13 | $206.23 | |
| Genzyme Corporation | 10 | $184.62 | |
| Lilly USA, LLC | 12 | $177.69 | |
| Arcutis Biotherapeutics, INC. | 9 | $156.54 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $147.22 | |
| Amgen INC. | 7 | $133.61 | |
| Regeneron Healthcare Solutions, INC. | 2 | $61.32 | |
| Leo Pharma INC. | 3 | $56.82 | |
| Novartis Pharmaceuticals Corporation | 2 | $50.64 | |
| Almirall LLC | 1 | $24.76 | |
| Galderma Laboratories, L.P. | 1 | $24.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
373
Patients
198
Total drug cost
$178,734
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 87 | 59 | $1,144 |
| Clobetasol Propionate | Generic | 55 | 39 | $6,376 |
| Ketoconazole | Generic | 45 | 27 | $831 |
| Doxycycline Hyclate | Generic | 43 | 26 | $1,165 |
| Betamethasone Dipropionate | Generic | 35 | 23 | $2,534 |
| Minoxidil | Generic | 24 | 0 | $214 |
| Clindamycin Phosphate | Generic | 22 | 11 | $660 |
| Dupixent Pen (Dupilumab) | Brand | 21 | 0 | $87,336 |
| Nystatin | Generic | 17 | 13 | $239 |
| Rinvoq (Upadacitinib) | Brand | 12 | 0 | $77,764 |
Frequently asked questions
What is Dr. Hownaz Binavi's medical specialty?
Dr. Hownaz Binavi practices Nurse Practitioner in San Diego, CA.
Where does Dr. Hownaz Binavi practice?
Dr. Hownaz Binavi practices at 6280 Jackson Dr Ste 8, San Diego, CA 921193436. Office phone: 6194641608.
What is Dr. Hownaz Binavi's NPI?
Dr. Hownaz Binavi's National Provider Identifier (NPI) is 1083276273, issued by NPPES.
Does Dr. Hownaz Binavi accept Medicare assignment?
Yes. Dr. Hownaz Binavi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Hownaz Binavi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.